INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 115 filers reported holding INSMED INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $535,000 | +42.7% | 22,607 | +35.8% | 0.05% | +48.4% |
| Q1 2018 | $375,000 | -8.1% | 16,649 | -30.0% | 0.03% | -16.2% |
| Q2 2017 | $408,000 | -50.0% | 23,781 | -71.3% | 0.04% | -64.1% |
| Q2 2016 | $816,000 | +281.3% | 82,799 | +619.2% | 0.10% | +53.7% |
| Q3 2015 | $214,000 | -48.6% | 11,512 | -32.4% | 0.07% | -55.0% |
| Q2 2015 | $416,000 | +161.6% | 17,027 | +39.6% | 0.15% | +65.6% |
| Q3 2014 | $159,000 | – | 12,195 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |